Gleamer, a Paris, France-based manufacturer of AI-powered solutions for medical imaging, raised $27 million in Series B financing, bringing its total funds raised to €36 million.
The round was led by Supernova Invest and co-led by Heal Capital, with participation from Gleamer's long-term partners XAnge, Elaia, Bpifrance, MACSF, Crista Galli Ventures, UI Investissement, and several European radiologists. This latest investment
The funding will enable Gleamer to expand its portfolio of solutions and enhance its offerings in the field of standard radiography.
Gleamer has developed AI-powered solutions such as BoneView for detecting bone trauma lesions, ChestView for detecting pulmonary pathologies, BoneMeasurement for automating MSK measurements, and BoneAge for automating bone age estimation. These solutions have MDR class IIa CE certification in Europe, and BoneView has also received FDA clearance for use in the United States.
With the new funding, Gleamer plans to extend its solutions to cover CT scans and mammography, aiming to address 70% of radiologists' daily needs.
The company will focus on strengthening its European and American teams, expanding its international presence, and forging new partnerships to make its solutions accessible to more people.
“This new round of funding will allow us to deepen Gleamer's mission of making AI the new standard of care in radiology. Our aim is to increase diagnostic accuracy and improve patient care and the efficiency of clinical practices for health professionals. We are delighted to have the support of Supernova Invest and Heal Capital, who not only have recognized deep expertise in this field, but also know how to support the commercial and technological development of growing companies positioned on global markets, such as Gleamer”, Christian Allouche, CEO and co-founder of Gleamer, explained.
Company: Gleamer SAS
Round: Series B
Funding Month: June 2023
Lead Investors: Supernova Invest, and Heal Capital
Additional Investors: XAnge, Elaia, Bpifrance, MACSF, Crista Galli Ventures, UI Investissement, and several European radiologists
Company Website: https://www.gleamer.ai/
Software Category: AI solutions for Radiology
About the Company: Founded in 2017, Gleamer considers AI to be a key solution for addressing the sharp rise in demand for medical imaging, stemming from the challenges of an ageing population, the increasing prevalence of chronic diseases, and the problems of access to healthcare. The company's suite of AI-powered solutions supports radiologists and clinicians in their diagnoses, thereby improving reliability and reducing the time taken to read and process examinations. Gleamer's solutions are already being used by over 6,500 users in 650 institutions across 24 countries, processing more than a million medical examinations each month. Gleamer have been rewarded by being named the EuroMinnies 2023 Best Vendor in Radiology winner, awarded by AuntMinnie Europe